Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-20

Clinical Trial Update: Reducing Risk of Recurrence [NA]

View source ↗

Summary

A VA-sponsored clinical trial to reduce recurrence risk after stroke or transient ischemic attack has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Office of Research and Development | Conditions: Stroke, TIA | NA | Status: COMPLETED | Results posted: 2016-10-20